0       0


TU3-25: Oral Abstract Session: Platelets and Pathogen Inactivation


Oct 22, 2019 11:00am ‐ Oct 22, 2019 12:30pm

Description

Oral Abstract Sessions:

5627: Achieving 100% Pathogen Reduced Platelet Component Inventory with Production Optimization and Variable Dosing
Presenting Author: Vera Chrebtow

6066: Sepsis from an Apheresis Platelet Contaminated with Acinetobacter Baumannii and Staphylococcus Saprophyticus after Pathogen Reduction
Presenting Author: Joy Fridey

5747: Five Years of Routine Experience Using Amotosalen/UVA-Treated Platelets with Storage up to 7 Days
Presenting Author: Laura Infanti

6224: An Evaluation of the Clinical Impact of 7 Day Platelets
Presenting Author: Shuoyan Ning

6122: Save a Platelet, Save a Life
Presenting Author: Arline Stein

Speaker(s):

  • Vera Chrebtow, Cerus Corporation
  • Joy L. Fridey, MD, MBA, American Red Cross
  • Laura Infanti, Regional Blood Transfusion Service, Swiss Red Cross Basel and Dept. of Hematology, University of Basel Hospital
  • Shuoyan Ning, MD, Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University
  • Arline Stein, North Shore University Hospital

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content